Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 2/20 | 1.00 |
| ▸ | GNB1 | P62873 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.69 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | GRK5 | P34947 | 1/20 | 0.31 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.31 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13320817 | 0.92 | GNG2 (0.85) | GNG2GNB1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL13320825 | 0.83 | GNG2 (1.00) | GNG2GNB1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL16556420 | 0.77 | GNG2 (0.59) | GNG2GNB1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL18102340 | 0.71 | GNG2 (0.56) | GNG2GNB1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL3903549 | 0.70 | GNG2 (0.54) | GNG2GNB1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL930322 | 0.70 | GNG2 (0.53) | GNG2GNB1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL23765023 | 0.69 | GNG2 (0.53) | GNG2GNB1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL30664408 | 0.69 | GNG2 (0.53) | GNG2GNB1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL2776491 | 0.69 | GNG2 (0.53) | GNG2GNB1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL19001731 | 0.69 | GNG2 (0.53) | GNG2GNB1ALDH1A1CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2010-05-27 | — | — | US | claimed |
| US-20220220561-A1 | METHODS AND CLINICAL PROTOCOLS AND KITS PERTAINING TO MAKING AND USING THERAPEUTIC COMPOSITIONS FOR CELLULAR TREATMENT | Advanced ReGen Medical Technologies, LLC | 2022-07-14 | — | — | US | disclosed |
| WO-2020190888-A1 | METHODS AND CLINICAL PROTOCOLS AND KITS PERTAINING TO MAKING AND USING THERAPEUTIC COMPOSITIONS FOR CELLULAR TREATMENT | Advanced ReGen Medical Technologies, LLC (US) | 2020-09-24 | — | — | WO | disclosed |
| US-10717981-B2 | Therapeutic compositions and methods of making and using the same | Advanced ReGen Medical Technologies, LLC (US) | 2020-07-21 | — | — | US | disclosed |
| WO-2019143847-A1 | THERAPEUTIC COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Advanced ReGen Medical Technologies, LLC (US) | 2019-07-25 | — | — | WO | disclosed |
| US-20190218558-A1 | THERAPEUTIC COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2019-07-18 | — | — | US | disclosed |
| US-8975259-B2 | Compositions and methods for inhibiting G protein signaling | UNIVERSITY OF ROCHESTER (US) | 2015-03-10 | — | — | US | disclosed |
| US-8975259-B2 | Compositions and methods for inhibiting G protein signaling | UNIVERSITY OF ROCHESTER (US) | 2015-03-10 | — | — | US | disclosed |
| US-8975259-B2 | Compositions and methods for inhibiting G protein signaling | UNIVERSITY OF ROCHESTER (US) | 2015-03-10 | — | — | US | disclosed |
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2010-05-27 | — | — | US | disclosed |
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2010-05-27 | — | — | US | disclosed |
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2010-05-27 | — | — | US | disclosed |
| EP-2147310-A2 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | University of Rochester (US) | 2010-01-27 | — | — | EP | disclosed |
| WO-2009020677-A9 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIV ROCHESTER (US) | 2009-04-16 | — | — | WO | disclosed |
| WO-2009020677-A9 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIV ROCHESTER (US) | 2009-04-16 | — | — | WO | disclosed |
| WO-2009020677-A2 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2009-02-12 | — | — | WO | disclosed |
| WO-2009020677-A2 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2009-02-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10717981-B2 | Therapeutic compositions and methods of making and using the same | PPM1F, PPM1A, PAX3 | GNG2 1165/4885GNB1 748/4885ALDH1A1 4113/4885 |
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | GNAI1, GNAI3, GNAI2 | GNG2 5/4885GNB1 4/4885ALDH1A1 4720/4885 |
| US-20190218558-A1 | THERAPEUTIC COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | PPM1F, PPM1A, PAX3 | GNG2 1165/4885GNB1 748/4885ALDH1A1 4113/4885 |
| US-20220220561-A1 | METHODS AND CLINICAL PROTOCOLS AND KITS PERTAINING TO MAKING AND USING THERAPEUTIC COMPOSITIONS FOR CELLULAR TREATMENT | CD47, HAVCR2, BST2 | GNG2 1936/4885GNB1 1570/4885ALDH1A1 2718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.